Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy

Pain Medicine

Volumn 11, Issue 3, 2010, Pages 456-465

  Toth, Cory ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Gabapentin; Neuropathic pain; Peripheral neuropathy; pregabalin

Indexed keywords

GABAPENTIN; PREGABALIN;

ADULT; ANALGESIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NEUROPATHIC PAIN; OPEN STUDY; OUTCOME ASSESSMENT; PERIPHERAL EDEMA; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; SEDATION; SIDE EFFECT; TERTIARY HEALTH CARE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; XEROSTOMIA;

EID: 77950967447     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00796.x     Document Type: Article

References (35)

1. Hughes RA. Peripheral neuropathy. BMJ 2002, 324(7335):466-9.
2. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997, 62(4):310-18.
3. Backonja MM, Galer BS. Pain assessment and evaluation of patients who have neuropathic pain. Neurol Clin 1998, 16(4):775-90.
4. Gore M, Brandenburg NA, Hoffman DL, Tai KS, Stacey B. Burden of illness in painful diabetic peripheral neuropathy: The patients' perspectives. J Pain 2006, 7(12):892-900.
5. Herrmann DN, Barbano RL, Hart-Gouleau S, Pennella-Vaughan J, Dworkin RH. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 2005, 6(5):379-84.
6. Koike H, Mori K, Misu K. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology 2001, 56(12):1727-32.
7. Toth C, Au S. A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy. Pain 2008, 138(3):657-66.
8. Gordon A, Choiniere M, Collet JP. The humanistic burden of neuropathic pain in Canada. J Outcomes Res 2006, 2006:23-35.
9. Mauskopf J, Austin R, Dix L, Berzon R. The Nottingham Health Profile as a measure of quality of life in zoster patients: Convergent and discriminant validity. Qual Life Res 1994, 3(6):431-5.
10. McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM. The burden of neuropathic pain: Results from a cross-sectional survey. Eur J Pain 2006, 10(2):127-35.
11. Meyer-Rosberg K, Kvarnstrom A, Kinnman E. Peripheral neuropathic pain-A multidimensional burden for patients. Eur J Pain 2001, 5(4):379-89.
12. Tarride JE, Collet JP, Choiniere M. The economic burden of neuorpathic pain in Canada. J Med Econ 2007, 9:55-68.
13. Moulin DE, Clark AJ, Gilron I. Pharmacological management of chronic neuropathic pain-Consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007, 12(1):13-21.
14. Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999, 159(16):1931-7.
15. Field MJ, Li Z, Schwarz JB. Ca2+ channel alpha2-delta ligands for the treatment of neuropathic pain. J Med Chem 2007, 50(11):2569-75.
16. Blommel ML, Blommel AL. Pregabalin: An antiepileptic agent useful for neuropathic pain. Am J Health Syst Pharm 2007, 64(14):1475-82.
17. Bril V, Perkins BA. Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. Diabetes Care 2002, 25(11):2048-52.
18. Perkins BA, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care 2001, 24(2):250-6.
19. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ 1998, 316:736-41.
20. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998, 280(21):1837-42.
21. Oster G, Harding G, Dukes E, Edelsberg J, Cleary PD. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: Results from a population-based survey. J Pain 2005, 6(6):356-63.
22. Backonja M, Beydoun A, Edwards KR. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998, 280(21):1831-6.
23. Dworkin RH, Backonja M, Rowbotham MC. Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003, 60(11):1524-34.
24. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001, 94(2):215-24.
25. Serpell MG. Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial. Pain 2002, 99(3):557-66.
26. Dworkin RH, Corbin AE, Young JP. Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology 2003, 60(8):1274-83.
27. Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115(3):254-63.
28. Lesser H, Sharma U, LaMoreaux L, Poole RM. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 2004, 63(11):2104-10.
29. Richter RW, Portenoy R, Sharma U. Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. J Pain 2005, 6(4):253-60.
30. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial. Pain 2004, 110(3):628-38.
31. Sabatowski R, Galvez R, Cherry DA. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 2004, 109(1-2):26-35.
32. Vartanian MG, Radulovic LL, Kinsora JJ. Activity profile of pregabalin in rodent models of epilepsy and ataxia. Epilepsy Res 2006, 68(3):189-205.
33. Argov Z, Steiner I, Soffer D. The yield of sural nerve biopsy in the evaluation of peripheral neuropathies. Acta Neurol Scand 1989, 79(3):243-5.
34. Gilron I, Bailey JM, Tu D. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352(13):1324-34.
35. Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: Current evidence and future directions. Expert Rev Neurother 2005, 5(6):823-30.